Aller au contenu principal
Auteurs
Alexandre Janer, Annie Sittler
Abstract

The present invention relates to use of an inducer of Promyelocytic Leukemia protein (PML) expression, and especially PML IV for the manufacture of a medicament intended for the treatment of polyglutamine expansion neurodegenerative diseases. More specifically, the present invention relates to the use of an interferon polypeptide for the manufacture of a medicament intended for the treatment of polyglutamine expansion neurodegenerative diseases.

Date de parution
Revue
Demande de brevet
Produit concerné